PDF
ePub
Citation
Print
Abstract
Background
Doxycycline, azithromycin, and chloramphenicol have been used for the treatment of scrub typhus; however, the duration of treatment for this disease is still controversial. Most clinical studies on the treatment of scrub typhus focus on the effectiveness of antibiotics; few studies have focused on the duration of the treatment. There has been no in vitro evaluation of the optimal duration of treatment of scrub typhus. We performed an experiment to evaluate the regrowth of Orientia tsutsugamushi after exposure to doxycycline of various concentration and exposure time.
Materials and Methods
O. tsutsugamushi strain Boryong was inoculated into the ECV304 cell line. The infected cells were stained with FS15, a monoclonal antibody reacting against a linear epitope on the 56-kDa major outer membrane protein of O. tsutsugamushi; thereafter, the antimicrobial susceptibilities were measured by flow cytometry and expressed as a growth index (total mass of Orientia). Incubation in media containing 0.1 (the minimal inhibitory concentration of doxycycline against O. tsutsugamushi strain Boryong), 0.2, and 2 µg/mL doxycycline for 1, 3, 5, and 7 day was followed by incubation in antibiotic-free media for 5 day. Two inocula sizes were employed; low inoculum (45.18% of cells were infected) and high inoculum (87.21% of cells).
Results
The incubation with 0.1 µg/mL doxycycline resulted in O. tsutsugamushi regrowth irrespective of doxycycline treatment duration. When the concentration of doxycycline was increased to 0.2 or 2 µg/mL, regrowth was observed in short duration treatments (1-5 day at 0.2 µg/mL; 1 day at 2 µg/mL). Higher inoculum size of O. tsutsugamushi increased regrowth (1 day at the low inoculum; 1-5 day at the high inoculum).
Conclusions
The regrowth of O. tsutsugamushi after doxycycline treatment depends on the doxycycline dose; the higher the dose, the lower the relapse rate. If this result is extrapolated to humans, higher dose of doxycycline might be preferred to lower the relapse rate. The inoculum effect in O. tsutsugamushi infection needs further investigations.
Figures and Tables
References
1. Raoult D, Drancourt M. Antimicrobial therapy of rickettsial diseases. Antimicrob Agents Chemother. 1991. 35:2457–2462.
2. Chung MH, Kang JS. Current clinical practice: treatment of tsutsugamushi disease. Korean J Med. 2002. 63:234–238.
3. Watt G, Kantipong P, Jongsakul K, Watcharapichat P, Phulsuksombati D. Azithromycin activities against Orientia tsutsugamushi strains isolated in cases of scrub typhus in Northern Thailand. Antimicrob Agents Chemother. 1999. 43:2817–2818.
4. Kim YS, Choi SY, Lee MS, Cheung DR, Kim EO, Woo JH, Ryu JS. Clinical and molecular biological investigation of therapeutic modalities and treatment duration of tsutsugamushi disease (Scrub typus). Korean J Chemother. 1999. 17:385–393.
5. Chung MH, Han SW, Choi MG, Chang WH, Pai HJ, Shin HS, Jung HJ, Kang MH, Jung JY. Comparison of a 3-day course of azithromycin with doxycycline for the treatment of scrub typhus. Korean J Infect Dis. 2000. 32:433–438.
6. Kim YS, Yun HJ, Shim SK, Koo SH, Kim SY, Kim S. A comparative trial of a single dose of azithromycin versus doxycycline for the treatment of mild scrub typhus. Clin Infect Dis. 2004. 39:1329–1335.
7. Smadel JE, Woodward TE, Ley HL, Lewthwaite R. Chloramphenicol (chloromycetin) in the treatment of tsutsugamushi disease (scrub typhus). J Clin Invest. 1949. 28:1196–1215.
8. Prezyna AP, Chang TL, Wang TL, Dougherty WJ, Bond HB. Treatment of scrub typhus in the Pescadores Islands with chloramphenicol, aureomycin and terramycin. Am J Trop Med Hyg. 1954. 3:608–614.
9. Kim MJ, Kim MK, Kang JS. Improved antibiotic susceptibility test of Orientia tsutsugamushi by flow cytometry using monoclonal antibody. J Korean Med Sci. 2007. 22:1–6.
10. Sheehy TW, Hazlett D, Turk RE. Scrub typhus. A comparison of chloramphenicol and tetracycline in its treatment. Arch Intern Med. 1973. 132:77–80.
11. Brown GW, Saunders JP, Singh S, Huxsoll DL, Shirai A. Single dose doxycycline therapy for scrub typhus. Trans R Soc Trop Med Hyg. 1978. 72:412–416.
12. Olson JG, Bourgeois AL, Fang RCY, Dennis DT. Burgdorfer W, Anacker RL, editors. Risk of relapse associated with doxycycline therapy for scrub typhus. Rickettsiae and rickettsial diseases. 1981. . New York: Academic Press, Inc;201–210. .
13. Twartz JC, Shirai A, Selvaraju G, Saunders JP, Huxsoll DL, Groves MG. Doxycycline prophylaxis for human scrub typhus. J Infect Dis. 1982. 146:811–818.
14. Song JH, Lee C, Chang WH, Choi SW, Choi JE, Kim YS, Cho SR, Ryu J, Pai CH. Short-course doxycycline treatment versus conventional tetracycline therapy for scrub typhus: a multicenter randomized trial. Clin Infect Dis. 1995. 21:506–510.
15. Lim JH, Lee SY, Lee JS, Choi S, Kim ES, Chung MH, Kang JS, Lee HJ, Cho YK, Lee SO. Preliminary report on the clinical efficacy of telithromycin for the treatment of scrub typhus. Infect Chemother. 2006. 38:39–44.
16. Kim DM, Yu KD, Lee JH, Kim HK, Lee SH. Controlled trial of a 5-day course of telithromycin versus doxycycline for treatment of mild to moderate scrub typhus. Antimicrob Agents Chemother. 2007. 51:2011–2015.
17. Kim JK, Joo HS, Yang JW, Lee WY, Yong SJ, Shin GC, Kim HY. Comparison of clinical manifestations by serotype of O. tsutsugamushi. Korean J Intern Med. 2002. 62:S152.
18. Ree HI, Kim TE, Lee IY, Jeon SH, Hwang UW, Chang WH. Determination and geographical distribution of Orientia tsutsugamushi serotypes in Korea by nested polymerase chain reaction. Am J Trop Med Hyg. 2001. 65:528–534.
19. Miyamura S, Sato N, Tamura A. In vitro susceptibility of recent clinical isolates of Rickettsia tsutsugamushi to chemotherapeutic agents. Kansenshogaku Zasshi. 1985. 59:486–488.
20. Miyamura S, Ohta T, Tamura A. Comparison of in vitro susceptibilities of Rickettsia prowazekii, R. rickettsii, R. sibirica and R. tsutsugamushi to antimicrobial agents. Nippon Saikingaku Zasshi. 1989. 44:717–721.
21. Chang WH, Kang JS, Lee WK, Choi MS, Lee JH. Serological classification by monoclonal antibodies of Rickettsia tsutsugamushi isolated in Korea. J Clin Microbiol. 1990. 28:685–688.
22. Lorain V. Antibiotics in Laboratory Medicine. 2005. 5th. Philadelphia: Lippincott William & Wilkins;727–790.
23. Silpapojakul K, Ukkachoke C, Krisanapan S, Silpapojakul K. Rickettsial meningitis and encephalitis. Arch Intern Med. 1991. 151:1753–1757.
24. Pai H, Sohn S, Seong Y, Kee S, Chang WH, Choe KW. Central nervous system involvement in patients with scrub typhus. Clin Infect Dis. 1997. 24:436–440.
25. Yim CW, Flynn NM, Fitzgerald FT. Penetration of oral doxycycline into the cerebrospinal fluid of patients with latent or neurosyphilis. Antimicrob Agents Chemother. 1985. 28:347–348.
26. Parkes R, Renton A, Meheus A, Laukamm-Josten U. Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Int J STD AIDS. 2004. 15:73–88.
27. Kim ES, Kim MK, Lee HM, Kil SH, Chung MH, Lee JS, Kang JS. oxycycline resistance in Orientia tsutsugamushi isolated from Korean patients. Infect Chemother. 2008. 40:260–266.
XML Download